Table 4: Effects of clinical parameters on seizure outcomes.

3 months6 months12 months

Age at the onset of first seizure (months)Responders13.47 ± 16.8516.96 ± 19.6618.92 ± 17.57
Nonresponders8.69 ± 7.277.71 ± 6.839.97 ± 13.24
value0.6150.1460.051

Age at the start of the SGT (months)Responders35.81 ± 34.7743.58 ± 38.2240.42 ± 31.54
Nonresponders28.71 ± 26.2324.07 ± 23.3531.62 ± 32.56
value0.7760.0860.139

Treatment duration (months)Responders22.34 ± 26.3726.62 ± 29.1621.50 ± 17.66
Nonresponders20.02 ± 26.3916.35 ± 22.5421.65 ± 28.29
value0.9700.3560.382

Number of AEDs that had been triedResponders3.00 ± 1.053.05 ± 1.162.92 ± 1.00
Nonresponders3.71 ± 1.213.38 ± 1.153.31 ± 1.18
value0.0300.2280.313

Data are presented as the mean ± SD. Mann-Whitney tests were used for comparison between responders and nonresponders. Statistically significant at .
SGT, Shihogyejitang; AED, antiepileptic drug.